Literature DB >> 29065984

Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?

Lotte van der Weijst1, Veerle Surmont2, Wim Schrauwen3, Yolande Lievens4.   

Abstract

Lung cancer and its treatment have an important impact on the patients' health-related quality-of-life (HRQoL). A systematic literature review of prospective clinical studies published since 2005 and measuring HRQoL in patients with locally-advanced non-small cell lung cancer (LA- NSCLC) was performed. Besides reviewing the HRQoL impact of LA-NSCLC treatment, it critically examined the frequency, methodology and quality of HRQoL data collection and analysis in LA-NSCLC clinical studies. Out of 814 potentially eligible publications, only 27 (representing 19 individual studies) met the inclusion criteria. Eight studies documented an impact on HRQoL. Large variability in use of HRQoL instruments, statistical analysis and methodological quality was observed. Reporting of HRQoL data lacks standardization, but recent initiatives establishing recommendations to standardize the analysis and reporting of HRQoL in cancer trials are expected to address these issues. Overall, more research is needed to evaluate the treatment impact on HRQoL in both clinical trials and daily care.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Health-related quality of life; Non-small cell lung cancer; Systematic literature review

Mesh:

Year:  2017        PMID: 29065984     DOI: 10.1016/j.critrevonc.2017.09.014

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  4 in total

1.  Frequency and Prognostic Impact of Consistently Low Edmonton Symptom Assessment System Score in the Patients Treated with Palliative Radiotherapy.

Authors:  Carsten Nieder; Thomas A Kämpe
Journal:  Cureus       Date:  2018-01-06

2.  Understanding the lived experience of lung cancer: a European social media listening study.

Authors:  Ana Rodrigues; Jyoti Chauhan; Alexandros Sagkriotis; Sathyaraj Aasaithambi; Michele Montrone
Journal:  BMC Cancer       Date:  2022-04-30       Impact factor: 4.638

3.  Commentary: When does the burden of treatment outweigh the biological benefit?

Authors:  Alisa N Blumenthaler; Mara B Antonoff
Journal:  JTCVS Open       Date:  2020-09-30

4.  Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long Study.

Authors:  Lotte Van Der Weijst; Veerle Surmont; Wim Schrauwen; Yolande Lievens
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.